Period:
Draw Mode:
| Volume | 11,254 |
|
|||||
| News | (1) | ||||||
| Day High | 3.18 | Low High |
|||||
| Day Low | 3.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lisata Therapeutics Inc | LSTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 3.58% | 3.18 | 16:36:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.11 | 3.00 | 3.18 | 3.18 | 3.07 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 239 | 11,254 | $ 3.06 | $ 34,449 | - | 2.36 - 9.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:29:33 | 2 | $ 3.30 | USD |
Lisata Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 24.99M | 7.86M | 7.78M | $ - | $ - | -7.83 | -0.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 254.24k | 16.70% |
Lisata Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LSTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.11 | 3.3263 | 2.98 | 3.08 | 4,541 | 0.07 | 2.25% |
| 1 Month | 3.00 | 3.6799 | 2.94 | 3.36 | 9,073 | 0.18 | 6.0% |
| 3 Months | 2.59 | 3.8282 | 2.59 | 3.42 | 12,280 | 0.59 | 22.78% |
| 6 Months | 4.44 | 5.16 | 2.36 | 3.59 | 14,458 | -1.26 | -28.38% |
| 1 Year | 8.80 | 9.38 | 2.36 | 4.95 | 34,935 | -5.62 | -63.86% |
| 3 Years | 8.80 | 9.38 | 2.36 | 4.95 | 34,935 | -5.62 | -63.86% |
| 5 Years | 8.80 | 9.38 | 2.36 | 4.95 | 34,935 | -5.62 | -63.86% |
Lisata Therapeutics Description
| Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. |